Search

Illumina Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

255.38 3.2

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

244.65

Max

254.12

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-268M

-134M

Pardavimai

68M

1.2B

P/E

Sektoriaus vid.

44.473

55.725

Pelnas, tenkantis vienai akcijai

1.31

Pelno marža

-11.562

Darbuotojai

8,600

EBITDA

80M

330M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

-18.83% downside

Dividendai

By Acuity

Kitas uždarbis

2026-10-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

7.4B

36B

Ankstesnė atidarymo kaina

252.18

Ankstesnė uždarymo kaina

255.38

Naujienos nuotaikos

By Acuity

32%

68%

53 / 339 reitingas Healthcare

Illumina Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-22 20:06; UTC

Illumina Inc is advancing, continuing its upward trajectory since Monday, peaking in the late afternoon and remaining above the 20-day moving average.

2026-09-21 20:06; UTC

Illumina Inc shares fell modestly after a mid-morning peak, though they remain above the 20-day moving average and near the upper end of their one-month range.

2026-09-18 23:06; UTC

Illumina Inc's stock is advancing in after-market trading, supported by mixed economic data and remaining above its 20-day moving average.

2026-09-17 23:06; UTC

Illumina Inc is trading modestly higher in after-market hours, supported by strong broader market performance and recent gains over the past month.

2026-09-16 23:01; UTC

Illumina Inc. is up in after-market trading, following five consecutive sessions of gains and trading significantly above its 20-day moving average.

2026-09-15 23:01; UTC

Illumina Inc's shares are trading higher in after-market hours, benefiting from a broader market rally despite mixed macroeconomic signals.

2026-09-14 20:08; UTC

Illumina Inc shares are higher today, though no specific news explains the move. Broader market concerns include rising crude oil prices and inflation.

2026-09-11 20:01; UTC

Illumina Inc's shares are higher Friday, continuing an upward trend since Thursday's close. No specific news was identified to explain the movement.

2026-09-09 20:07; UTC

Illumina Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

2026-09-08 23:51; UTC

Illumina Inc shares are higher in after-market trading, showing notable activity and positioning above the 20-day moving average amid a lack of specific news.

2026-09-05 00:05; UTC

News

Illumina Inc will join the S&P 500 on September 21, 2026. Shares are advancing in after-market hours following the announcement.

2026-09-04 23:02; UTC

News

Illumina Inc will join the S&P 500 index effective September 21, 2026, following an announcement by Dow Jones Indices. Shares are trading higher after the news.

2026-09-03 20:07; UTC

News

Illumina shares are higher as analysts raise price targets, with Argus at $235 and Baird at $225, reflecting increased confidence in the company.

2026-09-02 22:56; UTC

Illumina Inc's shares are higher in after-market hours following Wednesday's close, maintaining a position above its 20-day moving average. No specific news was identified.

2026-09-01 20:09; UTC

Illumina Inc's shares are lower today, continuing a downward trend observed since Monday. The stock has reached a session low, marking a third consecutive decline.

2026-08-31 23:36; UTC

Illumina Inc. shares declined in after-market trading, following hawkish comments from Federal Reserve Chair Kevin Warsh that affected market sentiment.

2026-08-28 23:16; UTC

Illumina Inc's shares are higher in after-market trading, reflecting positive momentum since Friday's close and routine trading activity within a narrow range.

2026-08-27 20:07; UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

2026-08-26 20:07; UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

2026-08-25 20:07; UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

2026-08-24 20:02; UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

2026-08-21 19:16; UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

2026-08-20 20:02; UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

2026-08-19 20:02; UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

2026-08-17 19:54; UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

2026-08-13 20:06; UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

2026-08-12 22:02; UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

2026-08-11 19:16; UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

2026-08-10 23:16; UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

2026-08-07 19:46; UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

Akcijų palyginimas

Kainos pokytis

Illumina Inc Prognozė

Kainos tikslas

By TipRanks

-18.83% į apačią

12 mėnesių prognozė

Vidutinis 200.875 USD  -18.83%

Aukščiausias 260 USD

Žemiausias 113 USD

Remiantis 17 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Illumina Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

17 ratings

9

Pirkti

5

Laikyti

3

Parduoti

Rinkos nuotaikos

By Acuity

53 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.